EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2025
|出版日期||內容資訊||英文 42 Pages
|EpiCast Report:心房纖維顫動的流行病學的預測 EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2025|
|出版日期: 2016年08月01日||內容資訊: 英文 42 Pages||
Atrial fibrillation (AF) is a disorder of the heart's conduction system. The condition is characterized by an irregular heart rhythm that is either too fast or too slow. During AF, the two upper chambers of the heart (atria) beat out of coordination with the two lower chambers (ventricles) due to disorganized electrical signals. Consequently, the blood doesn't flow as well as it should from the atria to the ventricles, resulting in poor blood supply to the rest of the body. AF symptoms typically include heart palpitations, chest discomfort, shortness of breath, dizziness, and weakness (CDC, 2015; Mayo Clinic, 2016; NHLBI, 2014). However, individuals with AF may be asymptomatic and not even know that they have the condition until it is identified through an electrocardiogram (ECG) test.
Although Atrial fibrillation (AF) affects people of all ages, the condition is rare in individuals younger than 40 years of age. The risk for AF increases rapidly with age and is more common in men than women. In 2010, AF affected approximately 33.5 million people globally (Chugh et al., 2013). Due to the asymptomatic nature of the condition, many cases go undetected. Even though the condition itself is not life-threatening, it can be uncomfortable and may require medical attention, as AF increases the risk for stroke, heart failure, and other heart-related complications (Mayo Clinic, 2016).
In the 8MM, epidemiologists forecast that the diagnosed prevalent cases of AF will increase from 9,487,217 cases in 2015 to 11,536,773 cases in 2025, at an Annual Growth Rate (AGR) of 2.16%. The US will have the highest number of diagnosed prevalent cases of AF among the 8MM throughout the forecast period, while Canada will have the lowest.
The report “EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2025 ” provides an overview of the risk factors, comorbidities, and the global and historical trends for AF in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of AF based on country-specific studies published in peer-reviewed journals. The diagnosed prevalent cases of AF are segmented by age (at 5-year intervals, starting at age 40 years), sex, and clinical subtypes (paroxysmal, persistent, and permanent AF) in the 8MM.